泰福-KY 6541
Listed · Biotechnology and medical care28.150 (0%)After close
- Prev close
- 28.15
- Volume (shares)
- 150,422
- Data time
- 2026-11-11 13:30:00
- Open
- —
- High
- —
- Low
- —
- Prev close
- 28.15
- Volume (lots)
- —
- Turnover
- —
- P/E
- —
- Cash yield
- —
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | -102.49% | -200.66% | -136.19% | -129.50% | -27.03% | -44.18% | 51.60% | 57.47% |
| Operating margin | -166.52% | -301.32% | -208.75% | -228.42% | -682.98% | -819.39% | -9,872.85% | -2,558.75% |
| Net margin | -173.53% | -292.65% | -235.00% | -218.21% | -727.01% | -934.07% | -9,900.71% | -2,768.47% |
| ROE (TTM) | -29.78% | -26.08% | -45.55% | -37.98% | -44.17% | -48.00% | -161.17% | -128.72% |
| ROA (TTM) | -20.17% | -18.61% | -28.05% | -24.32% | -27.28% | -27.43% | -50.25% | -50.40% |
| EPS, quarter (TWD) | -1.44 | -1.47 | -1.60 | -1.03 | -1.41 | -2.09 | -1.65 | -1.88 |
| EPS, TTM (TWD) | -5.54 | -5.38 | -6.13 | -5.70 | -6.09 | -6.41 | -8.90 | -10.65 |
No data.
Revenue in NT$100M; 12 months per page.
No data.
Amounts in NT$100M (per-share items in NT$).
No data.
Amounts in NT$100M (per-share items in NT$).
No data.
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 146.75% | — | — | — | — | — | — | — |
| Debt ratio | 34.96% | 29.77% | 28.48% | 26.59% | 29.30% | 27.50% | 67.34% | 61.59% |
| Equity ratio | 65.04% | 70.23% | 71.52% | 73.41% | 70.70% | 72.50% | 32.66% | 38.41% |
| Equity multiplier | 1.54 | 1.42 | 1.40 | 1.36 | 1.41 | 1.38 | 3.06 | 2.60 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.09 | 0.06 | 0.07 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 |
| Equity turnover | 0.13 | 0.09 | 0.12 | 0.06 | 0.03 | 0.03 | 0.04 | 0.03 |
Source: MOPS. For reference only; not investment advice.